Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
287,260
-
Share change
-
+287,260
-
Total reported value
-
$2,124,000
-
Price per share
-
$7.39
-
Number of holders
-
13
-
Value change
-
+$2,124,000
-
Number of buys
-
13
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2019
As of 31 Mar 2019,
PDS Biotechnology Corp - Common (PDSB) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
287,260 shares.
The largest 10 holders included
Sofinnova Investments, Inc., RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Samsara BioCapital, LLC, BRONFMAN E.L. ROTHSCHILD, L.P., PANAGORA ASSET MANAGEMENT INC, and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.